Group One Trading
NXTM

Group One Trading’s NxStage Medical Inc. NXTM Stock Holding History

Group One Trading’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,500
Closed -$186K – 5730
2018
Q4 		$186K Buy
6,500
+4,000
+160% +$114K ﹤0.01% 2742
2018
Q3 		$70K Buy
2,500
+2,000
+400% +$56.2K ﹤0.01% 3775
2018
Q2 		$14K Sell
500
-5,500
-92% -$147K ﹤0.01% 4527
2018
Q1 		$149K Sell
6,000
-1,100
-15% -$26.8K ﹤0.01% 2993
2017
Q4 		$172K Sell
7,100
-22,300
-76% -$588K ﹤0.01% 3024
2017
Q3 		$811K Buy
29,400
+28,800
+4,800% +$768K 0.01% 1715
2017
Q2 		$15K Sell
600
-2,700
-82% -$66.8K ﹤0.01% 4067
2017
Q1 		$89K Buy
+3,300
New +$91.2K ﹤0.01% 3053
2016
Q4 		– Sell
-7,400
Closed -$185K – 5082
2016
Q3 		$185K Buy
+7,400
New +$173K ﹤0.01% 2525
2014
Q4 		– Sell
-9,000
Closed -$118K – 5511
2014
Q3 		$118K Sell
9,000
-800
-8% -$10.8K ﹤0.01% 2846
2014
Q2 		$141K Buy
9,800
+7,200
+277% +$94K ﹤0.01% 2688
2014
Q1 		$33K Buy
+2,600
New +$33.9K ﹤0.01% 3934
2013
Q3 		– Sell
-11,200
Closed -$160K – 5813
2013
Q2 		$160K Buy
+11,200
New +$141K ﹤0.01% 2380

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Group One Trading's NXTM Position: Q1 2019 in Review

Group One Trading sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,322 shares — an estimated $38K sold.

Group One Trading first reported a position in NXTM in Q3 2013 and held it in 16 quarters. The position peaked at $492K in Q3 2015. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Group One Trading reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Group One Trading sold 1,322 NxStage Medical Inc. shares in Q1 2019, an estimated $38K.
  • Group One Trading first reported a position in NxStage Medical Inc. in Q3 2013 and held it in 16 quarters.
  • Group One Trading's NxStage Medical Inc. position peaked at $492K in Q3 2015.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.